NewsRoom Articles - Page 80 of 207

TuesdayJan 10, 2023 12:42 pm

Scientific Review Highlights Stigma Directed at People Living with Chronic Pain

The International Association for the Study of Pain estimates that 20% of people worldwide live with chronic pain, with low- and middle-income countries reporting a higher chronic pain prevalence of around 33%. A recent scientific review by researchers from the Sapienza University of Rome has now revealed that chronic pain sufferers are increasingly becoming victims of stigma. Stigma is defined by the World Health Organization (WHO) as a mark of disgrace, shame or disapproval that results in discrimination and exclusion from the community. When patients suffer from stigmatized conditions such as HIV/AIDS, obesity, and chronic pain, they are much less…

TuesdayJan 10, 2023 12:00 pm

Aditxt, Inc. (NASDAQ: ADTX) Bolsters Goal to Conduct First-In-Human Clinical Trial Evaluating ADI(TM) Tech with Formation of Adimune, Inc. Subsidiary; Appoints Industry Veteran as Subsidiary Chairman and CEO

Aditxt recently announced the formation of a U.S.-based wholly owned subsidiary, Adimune, Inc., and appointed Joachim-Friedrich Kapp, M.D., Ph.D., a 30-year veteran of the pharmaceutical industry, as its Chairman and CEO Dr. Kapp will be tasked with leading and developing the Apoptotic DNA Immunotherapy(TM) (“ADI(TM)”) technology toward clinical trials Aditxt also plans to submit a Clinical Trial Application (“CTA”) for immunotherapeutic technology drug candidate ADI(TM)-100, seeking approval for Adimune(TM) to conduct the first-in-human study in psoriasis patients, beginning in the second half of 2023 ADI(TM) is a nucleic acid-based technology platform that utilizes a novel antigen-specific approach to induce immune…

TuesdayJan 10, 2023 10:30 am

MetAlert, Inc. (MLRT) Developing Innovative Location-Sensitive Health Monitoring and Supervision Products as It Targets Market Leadership in Telehealth Space

MetAlert is a pioneer in location-sensitive health monitoring devices and wearable technology products targeting the Alzheimer’s, Dementia, and Autism (“ADA”) market The company is looking to provide cutting-edge telehealth technologies and is continuously working to roll out improved and more innovative products for its users Its SmartSole(R) product facilitates discreet tracking and remote monitoring of ADA patients The company has also launched SmartSole plus(R), which adds Bluetooth and Wi-Fi capabilities for better tracking MetAlert also distributes RoomMate, a wall-mounted 3D infrared supervision product that enables caregivers to look after patients without intruding on their personal space The policy changes spearheaded…

MondayJan 09, 2023 10:43 am

America Faces Shortage of Infectious Disease Experts

The United States is currently facing a critical shortage of infectious disease experts. Infectious disease doctors, or IDs as they are commonly referred to in hospitals, are usually tasked with diagnosing diseases and guiding hospital teams in treatment. This tends to involve collecting extensive and detailed medical histories and reviewing past medical records thoroughly to identify the root cause of a patient’s symptoms. Unsurprisingly, this infectious disease expert work requires a tremendous amount of cognitive effort and plays a critical role in the proper diagnosis and treatment of patients. It also requires key qualifications, with ID doctors having to go…

FridayJan 06, 2023 10:47 am

Why a Dog’s Teeth May Chatter

Similar to humans, animals such as dogs have unique behaviors they exhibit from time to time. While most quirks are adorable, teeth chattering may be caused by severe underlying issues. To help you understand why your dog’s teeth are chattering, below we look at reasons why that may happen. Your dog is cold Your dog’s teeth may chatter when it is in a cold environment. This shows that the animal is not comfortable with the current temperature, so if it is outside, you should bring your pet inside. Alternatively, if an animal’s teeth are chattering while inside the house, then…

FridayJan 06, 2023 10:30 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Receives $57 Share Valuation on Potential of NanoAb Platform

BiondVax Pharmaceuticals was recently featured in a research report by Zacks Small-Cap Research The report highlighted BiondVax’s recent achievements, the most notable of which is the proof-of-concept animal trial that delivered positive results suggesting that the company’s anti-COVID-19 NanoAb candidate resulted in milder and shorter illness The company also received support and advice from the Paul Ehrlich Institute (“PEI”), which are viewed as key toward approval for a Phase 1/2a first-in-human clinical trial The report estimates that BiondVax is fully funded for the next 12 months; subsequent to the report’s publication, BiondVax raised an additional $7.3 million net in an…

FridayJan 06, 2023 9:45 am

MetAlert, Inc. (MLRT) – Offering More Than Location-Sensitive Health Monitoring Devices

The CDC estimates that by 2060, over 14 million Americans may be diagnosed with Alzheimer’s, up from the current 6.5 million In a surprising study, presented at the 2022 Alzheimer’s Association International Conference, it was noted that this rise could be largely attributed to people’s intake of ultra-processed foods, which was linked to a higher risk of dementia Of the 10,000 participants who took part in the study, it was noted that those who ate the most ultra-processed foods had a 28% faster rate of global cognitive decline, and a 25% faster rate of executive function decline compared to those…

ThursdayJan 05, 2023 10:20 am

Four Developments in Cancer Research That Occurred in 2022

Cancer is a leading cause of death globally, with cancer types such as lung cancer, breast cancer and colorectal cancer being responsible for most cancer deaths. Over the last year, research in this particular field has made significant strides. Below, we look at some of the developments that occurred in 2022. CAR T-cell therapy proving to be revolutionary The FDA first approved the first CAR T-cell immunotherapy in 2017. Since then, the technology has shown great promise in the treatment of various cancers. Chimeric antigen receptor (CAR) T-cell therapy usually involves genetically engineering an individual’s immune cells to better identify…

WednesdayJan 04, 2023 9:54 am

New Treatment Approach for Cancer Combines Bacterial, Pharmaceutical Therapy

Lung cancer is the deadliest type of cancer in the United States, causing more than 100,000 deaths annually, which is more casualties than other kinds of cancers combined. Current lung-cancer treatments include chemotherapy, surgery, targeted therapy, radiation therapy or a combination of these approaches. Treatment can be up to 90% effective if the cancer is still small and in early stages, but success rates drop as the tumor becomes larger and more advanced. As the risk of cancer in people under age 50 has increased dramatically, scientists across the country have dedicated their time and energy to discovering even more…

WednesdayJan 04, 2023 9:45 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Releases Business Updates and Announces CEO’s Upcoming Speaking Engagements

BiondVax has released statistically significant results showing efficacy of its inhaled NanoAb as anti-COVID-19 therapy, as part of a preclinical proof-of-concept animal study The study was conducted in collaboration with the world-renowned institutes Fraunhofer Institute for Toxicology and Experimental Medicine (“ITEM”) and The University of Veterinary Medicine Hannover (“TiHo”) The technology is exclusively licensed from the prestigious Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Gottingen CEO Amir Reichman is scheduled to present in person at the Biotech Showcase (San Francisco – January 9th during JPM Healthcare conference week) and the BIO CEO & Investor Conference (New…